Assignee
SpecGx LLC
US·15 granted patents·8 pending applications·5 citations·filing 2015–2025
Top patents by PatentIndex Score
23 records- 0183US2025368630A1Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2025·Application pending·0 cites
- 0281US12371423B2Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2022·Granted Jul 29, 2025·0 cites·21 claims
- 0378US11077024B2Systems and methods for high humidity curing within tablet coating systemSpecGx LLC·Filed 2019·Granted Aug 3, 2021·2 cites·17 claims
- 0477US10927068B2Process for preparing acylated amphetamine derivativesSpecGx LLC·Filed 2018·Granted Feb 23, 2021·1 cites·17 claims
- 0576US2022079938A1Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compoundsSpecGx LLC·Filed 2021·Application pending·0 cites
- 0675US11033508B2Delayed sustained release pharmaceutical compositionsSpecGx LLC·Filed 2018·Granted Jun 15, 2021·2 cites·7 claims
- 0773US12208094B2Extended release, abuse deterrent dosage formsSpecGx LLC·Filed 2022·Granted Jan 28, 2025·0 cites·20 claims
- 0873US2019381033A1PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSSpecGx LLC·Filed 2019·Application pending·0 cites
- 0972US2021061793A1Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2020·Application pending·0 cites
- 1071US11096887B2Extended release, abuse deterrent pharmaceutical compositionsSpecGx LLC·Filed 2019·Granted Aug 24, 2021·0 cites·15 claims
- 1170US2020338068A1PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSSpecGx LLC·Filed 2020·Application pending·0 cites
- 1267US11666509B2Systems and methods for high humidity curing within tablet coating systemSpecGx LLC·Filed 2021·Granted Jun 6, 2023·0 cites·14 claims
- 1365US10899749B2Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2019·Granted Jan 26, 2021·0 cites·10 claims
- 1464US11583493B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2020·Granted Feb 21, 2023·0 cites·16 claims
- 1564US11517521B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2018·Granted Dec 6, 2022·0 cites·8 claims
- 1663US11446293B2Extended release, abuse deterrent dosage formsSpecGx LLC·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 1762US2018280289A1Immediate release, abuse deterrent pharmaceutical compositionsSpecGx LLC·Filed 2018·Application pending·0 cites
- 1860US2019358164A1Zero-order modified release solid dosage formsSpecGx LLC·Filed 2019·Application pending·0 cites
- 1956US11617712B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2015·Granted Apr 4, 2023·0 cites·20 claims
- 2053US11065246B2Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent propertiesSpecGx LLC·Filed 2017·Granted Jul 20, 2021·0 cites·18 claims
- 2149US11478426B2Abuse deterrent immediate release capsule dosage formsSpecGx LLC·Filed 2019·Granted Oct 25, 2022·0 cites·16 claims
- 2242US2019183896A1One step milling process for preparing micronized paliperidone estersSpecGx LLC·Filed 2018·Application pending·0 cites
- 2338US11464741B2Spray dried compositions having different dissolution profiles and processes for their preparationSpecGx LLC·Filed 2015·Granted Oct 11, 2022·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when SpecGx LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →